23. Manipulación de eventos fisiológicos – Autoreplicación de Nanobots
¿Enfermedades no Biológicas?
¿Quién Ejercerá Control?
¿Acceso Para Todos?
¿PLAGA GRIS?
24. • CLAVIJO-GRIMALDI, D., GARCÍA, G.A., CASADIEGO, C.A. Nanotecnología en el diagnóstico y
tratamiento médico. En: Univ Méd Bogotá. 2008, vol. 49, no. 3, p. 388-398.
• MIN, F., CHUN-WEI, P., DAI-WEN, P., YAN, L. Quantum dots for cancer research. Currents
status, remaining issues, and futures perspectives. En: Cancer Biol Med. 2012, vol. 9, p. 151-163.
• LEE, J., NAN, A. Combination drug delievery approaches in metastatic breast cancer. En: J Drug Deliev.
2012,
• MING-HSIN, L., SEOK-KI, C., JAMES, B.J. Dendrimer-based multivalent methorexates as dual acting
nanoconjugates for cancer cell targeting. En: Eur J Med Chem. 2012, vol. 47.
• PASTRANA, H.F. Nanomedicina: estado del arte. En: Rev Ingenieria Univ Andes. 2007, vol. 25.
• POMBO-BARROS, V., GOYANES-VILLAESCUSA, V. Quantum dots: the new contribution of
nanotechnology to research and medicine. En: Rev Compl Cien Vet. 2011, vol. 5, no. 1, p. 69-102.
• RUEI-MIN, L., MIN-SHAN, C., HAN-CHUNG, W. Targeted drug delievery systems mediated by a novel
peptide in breast cancer therapy and imaging. En: Plos One. 2013, vol. 8, no. 6.
• YAZDAN-MADANI, S., NADERI, N., SEIFALIAN, A.M. A new era of cancer treatment: carbon nanotubes
as drug delievery tools. En: Int J Nanomedicine. 2011, vol. 6, p. 2963-2979.
• ZDOBNOVA, T.A., LEBEDENKO, E.N., DEYEV, S.M. Quantum dots for molecular diagnostic of tumors. En:
Acta Naturae. 2011, vol. 3, no. 1, p. 29-47.
• ZHANG, L., ZHANG, N. How nanotechnology can enhance docetaxel therapy. En: Int J Nanomedicine.
2013, vol. 8, p. 2927-2941.